These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7726931)

  • 1. Comments on "Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio".
    Cheng SH; Jian JJ; Huang AT
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):682-3. PubMed ID: 7726931
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio.
    Sham J; Choy D; Kwong PW; Cheng AC; Kwong DL; Yau CC; Wan KY; Au GK
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):699-704. PubMed ID: 8040015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI of the hypothalamus and pituitary gland in patients with hyperprolactinaemia following radiotherapy for nasopharyngeal carcinoma.
    Lau KY; Sze WM; Lee AW; Yau TK; Fung WT; Chan PO
    Singapore Med J; 2001 Sep; 42(9):406-9. PubMed ID: 11811606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypopituitary dwarfism following radiotherapy for nasopharyngeal carcinoma.
    Tan BC; Kunaratnam N
    Clin Radiol; 1966 Jul; 17(3):302-4. PubMed ID: 5942779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
    Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
    Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary function in long-term survival after radiation therapy of nasopharyngeal tumours.
    de Schryver A; Ljunggren JG; Båryd I
    Acta Radiol Ther Phys Biol; 1973 Dec; 12(6):497-508. PubMed ID: 4132405
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperprolactinemic amenorrhea after external irradiation for nasopharyngeal carcinoma.
    Tang LC; Ma HK
    Fertil Steril; 1983 Jul; 40(1):118-9. PubMed ID: 6407875
    [No Abstract]   [Full Text] [Related]  

  • 8. Technical and dosimetric considerations in multi-isocenter intensity modulated radiotherapy for nasopharyngeal carcinoma with small multileaf collimator.
    Xiance J; Shixiu W; Jianyi Y; Jinling Y
    Med Dosim; 2009; 34(1):9-15. PubMed ID: 19181249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation radiotherapy for nasopharyngeal tumor.
    Kitabatake T; Hinata H; Inakoshi H
    Strahlentherapie; 1971; 141(3):300-5. PubMed ID: 4996070
    [No Abstract]   [Full Text] [Related]  

  • 10. Sparing submandibular gland by IMRT.
    Saibishkumar EP; Jha N
    Radiother Oncol; 2006 Jul; 80(1):106. PubMed ID: 16876273
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dosimetric evaluation for three dimensional conformal, conventional, and traditional radiotherapy plans for patients with early nasopharyngeal carcinoma].
    Luo W; Deng XW; Lu TX
    Ai Zheng; 2004 May; 23(5):605-8. PubMed ID: 15142465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Moulded appliances in radium therapy].
    Pierquin B; Chassagne D; Janvier L; Lecacheux B
    Actual Odontostomatol (Paris); 1967 Mar; 77():61-75. PubMed ID: 6067020
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant astrocytoma following radiation for nasopharyngeal carcinoma: case report and review of the literature.
    Lin KC; Cheng TJ; Yung JM; Kuo JR
    Acta Neurol Taiwan; 2007 Mar; 16(1):27-32. PubMed ID: 17486730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies.
    Contrera KJ; Phan J; Waguespack SG; Aldehaim M; Wang X; Lim TY; Roberts DB; Fuller CD; Spiotto MT; Raza SM; DeMonte F; Hanna EY; Su SY
    Head Neck; 2023 Oct; 45(10):2525-2532. PubMed ID: 37534890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
    Chen M; Lin S; Zheng W
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings.
    King AD; Ahuja AT; Yeung DK; Wong JK; Lee YY; Lam WW; Ho SS; Yu SC; Leung SF
    Clin Radiol; 2007 Mar; 62(3):195-203. PubMed ID: 17293211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma.
    Li JJ; Guo YK; Tang QL; Li SS; Zhang XL; Wu PA; Yang XM
    J Laryngol Otol; 2010 Jan; 124(1):32-6. PubMed ID: 19840426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma.
    Cheng SH; Liu TW; Jian JJ; Tsai SY; Hao SP; Huang CH; Liu MC; Yu B; Huang AT
    Cancer J Sci Am; 1997; 3(2):100-6. PubMed ID: 9099460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
    Frikha M; Toumi N; Ghorbel L; Ben Salah H; Khabir A; Karray H; Gargouri R; Boudawara T; Ghorbel A; Daoud J
    Cancer Radiother; 2010 Jun; 14(3):169-75. PubMed ID: 20347607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.